Sun.Feb 23, 2025

article thumbnail

Fainting: Simple Tips to Stay Safe

Drugs.com

SUNDAY, Feb. 23, 2025 -- Fainting can be scary, but it's often harmless. Known medically as syncope, fainting happens when there’s not enough blood flow to the brain, causing a brief loss of consciousness. But how do you know if it's just a.

147
147
article thumbnail

New Benzothiazole‐Thiadiazole‐Based Ketones as Potential Antiviral and Anticancer Agents: Synthesis, DFT, and Molecular Docking Studies

Chemical Biology and Drug Design

ABSTRACT Various substituted benzothiazole-thiadiazole-based ketones 4a-i and 6a-c were synthesized and characterized by the IR, NMR, and MS spectral data. The DFT study of the synthesized ketones 4 and 6 displayed matched configurations of their HOMO and LUMO, with the exception of the nitrophenyl derivatives, whose HOMO extended over the entire molecule.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Warning Letters: An Untapped Source for Understanding When Device Changes Require a New 510(k)

FDA Law Blog: Biosimilars

By Steven J. Gonzalez & Allyson B. Mullen As the device industry is well aware, one of the greyest areas in device regulation (of which there are many) is determining when changes to a 510(k)-cleared device trigger the need for a new clearance. FDA requires a new 510(k) clearance when a modification to an existing 510(k)-cleared device (or other existing device subject to 510(k) requirements) could significantly affect the safety or effectiveness of the device.

FDA 64
article thumbnail

Analyzing the cost-effectiveness of biosimilars in different healthcare systems

Drug Patent Watch

The Cost-Effective Future of Medicine: Unpacking the Potential of Biosimilars As healthcare systems around the world continue to grapple with the rising costs of medication, a new solution is emerging: biosimilars. These highly similar versions of biologic medicines have the potential to revolutionize the way we approach healthcare costs, but how effective are they really?

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

How To Create High Availability Kubernetes Cluster on AWS using KUBEONE: Part-2

Perficient: Drug Development

In Part-1 , we learned about the importance of KUBEONE. Now, lets explore on demo part in this practical session will focus on creating High Availability Kubernetes Cluster on AWS using KUBEONE Setup KubeOne 1. Downloading KubeOne CREATE ec2 instance first with any type as suitable, then download KubeOne from below script. The below commands will be used to download KubeOne sudo apt-get update sudo apt-get -y install unzip curl -sfL [link] | sh The above script downloads the latest version of Ku